FDA — authorised 22 January 1991
- Marketing authorisation holder: HOSPIRA
- Status: approved
FDA authorised Lavopa on 22 January 1991
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 22 January 1991.
HOSPIRA holds the US marketing authorisation.